Sandoz Shuffles Management And Sets Out Restructuring Plans

As ‘Fantastic Progress’ On Biosimilars Drives Sales Growth Of Almost A Tenth In Q2

Sandoz has revealed senior management changes and details of a restructuring plan to drive efficiencies, as the firm unveiled positive results for the second quarter of 2024 that saw biosimilars continue to drive solid growth for the company.

Company structure, management layers
Sandoz is reducing layers and simplifying its organization • Source: Shutterstock

Sandoz has announced management changes that have seen the firm announce a new chief commercial officer and head of Europe, at the same time as the company revealed details of a restructuring plan that would “reduce layers across the organization and simplify our processes” to drive efficiencies.

Pierre Bourdage, Sandoz’s chief commercial officer, is “unfortunately stepping down from his role for personal health reasons,” the company disclosed

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

More from Generics Bulletin